167 related articles for article (PubMed ID: 10561618)
1. Second-trimester uterine evacuation: A comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol.
Perry KG; Rinehart BK; Terrone DA; Martin RW; May WL; Roberts WE
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1057-61. PubMed ID: 10561618
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study.
Ghorab MN; El Helw BA
Acta Obstet Gynecol Scand; 1998 Apr; 77(4):429-32. PubMed ID: 9598952
[TBL] [Abstract][Full Text] [Related]
6. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol.
Jain JK; Meckstroth KR; Mishell DR
Am J Obstet Gynecol; 1999 Dec; 181(6):1386-91. PubMed ID: 10601917
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
Goel A; Mittal S; Taneja BK; Singal N; Attri S
Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
[TBL] [Abstract][Full Text] [Related]
8. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy.
Su LL; Biswas A; Choolani M; Kalaichelvan V; Singh K
Am J Obstet Gynecol; 2005 Oct; 193(4):1410-4. PubMed ID: 16202734
[TBL] [Abstract][Full Text] [Related]
10. Second trimester pregnancy termination using extra-amniotic ethacridine lactate.
Bhathena RK; Sheriar NK; Walvekar VR; Guillebaud J
Br J Obstet Gynaecol; 1990 Nov; 97(11):1026-9. PubMed ID: 2123711
[TBL] [Abstract][Full Text] [Related]
11. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion.
Nuutila M; Toivonen J; Ylikorkala O; Halmesmäki E
Obstet Gynecol; 1997 Dec; 90(6):896-900. PubMed ID: 9397098
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review.
Gómez Ponce de León R; Wing DA
Contraception; 2009 Apr; 79(4):259-71. PubMed ID: 19272495
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
14. The use of misoprostol for mid-trimester therapeutic termination of pregnancy.
Munthali J; Moodley J
Trop Doct; 2001 Jul; 31(3):157-61. PubMed ID: 11444340
[TBL] [Abstract][Full Text] [Related]
15. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination.
Dickinson JE; Evans SF
Am J Obstet Gynecol; 2002 Mar; 186(3):470-4. PubMed ID: 11904609
[TBL] [Abstract][Full Text] [Related]
16. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
17. Second trimester abortion by laminaria followed by vaginal misoprostol or intrauterine prostaglandin F2alpha: a randomized trial.
Paz B; Ohel G; Tal T; Degani S; Sabo E; Levitan Z
Contraception; 2002 Jun; 65(6):411-3. PubMed ID: 12127639
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol for uterine evacuation in patients with early pregnancy failures.
Murchison A; Duff P
Am J Obstet Gynecol; 2004 May; 190(5):1445-6. PubMed ID: 15167864
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.
Dickinson JE; Godfrey M; Evans SF
J Matern Fetal Med; 1998; 7(3):115-9. PubMed ID: 9642607
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
